Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA
This article was originally published in The Rose Sheet
Executive Summary
FDA top leadership team will not split up duties along food and medical products, sources close to the selection process say
You may also be interested in...
Idea Of Dividing Food, Drugs At HHS Raises Question: What About Cosmetics?
With the Obama Administration focused on overhauling FDA's food safety program and stakeholders calling for designated regulatory leadership and even a separate food agency altogether, some are beginning to question what fate has in store for cosmetics and dietary supplements
Idea Of Dividing Food, Drugs At HHS Raises Question: What About Cosmetics?
With the Obama Administration focused on overhauling FDA's food safety program and stakeholders calling for designated regulatory leadership and even a separate food agency altogether, some are beginning to question what fate has in store for cosmetics and dietary supplements
Hamburg/Sharfstein Choice Underscores Public Health, Stricter Oversight
The White House's appointment of two former health commissioners to run FDA sends a strong message that the agency is refocusing on public health